{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:08:29Z","timestamp":1791299309393,"version":"4.1.0"},"reference-count":223,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcehepatology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical and Experimental Hepatology"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.jceh.2014.04.003","type":"journal-article","created":{"date-parts":[[2014,5,22]],"date-time":"2014-05-22T08:31:46Z","timestamp":1400747506000},"page":"S3-S26","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":68,"special_numbering":"S3","title":["The Indian National Association for Study of the Liver (INASL) Consensus on Prevention, Diagnosis and Management of Hepatocellular Carcinoma in India: The\u00a0Puri Recommendations"],"prefix":"10.1016","volume":"4","author":[{"given":"Ashish","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subrat K.","family":"Acharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivaram P.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek A.","family":"Saraswat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay","family":"Duseja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahesh K.","family":"Goenka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepali","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Premashish","family":"Kar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinay","family":"Kumaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunisshery M.","family":"Mohandas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dipanjan","family":"Panda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shashi B.","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeyamani","family":"Ramachandran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hariharan","family":"Ramesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Padaki N.","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir R.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanish","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ragesh B.","family":"Thandassery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jceh.2014.04.003_bib1","unstructured":"CEBM > EBM Tools > Finding the Evidence > Levels of Evidence 2 > Levels of Evidence 1. Available at: http:\/\/www.cebm.net\/index.aspx?o=1025. Accessed 24.02.13."},{"key":"10.1016\/j.jceh.2014.04.003_bib2","unstructured":"PBCR Reports 2006\u20132008\u2026 Available at: http:\/\/www.ncrpindia.org\/Reports\/PBCR_2006_2008.aspx. Accessed 24.02.13."},{"key":"10.1016\/j.jceh.2014.04.003_bib3","unstructured":"Cancer Incidence in Five Continents. Available at: http:\/\/ci5.iarc.fr\/. Accessed 24.02.13."},{"issue":"9828","key":"10.1016\/j.jceh.2014.04.003_bib4","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/S0140-6736(12)60358-4","article-title":"Cancer mortality in India: a nationally representative survey","volume":"379","author":"Dikshit","year":"2012","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.jceh.2014.04.003_bib5","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1056\/NEJMra1001683","article-title":"Hepatocellular carcinoma","volume":"365","author":"El-Serag","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.jceh.2014.04.003_bib6","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1053\/j.gastro.2007.04.061","article-title":"Hepatocellular carcinoma: epidemiology and molecular carcinogenesis","volume":"132","author":"El-Serag","year":"2007","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.jceh.2014.04.003_bib7","first-page":"274","article-title":"Incidence of hepatocellular carcinoma among Indian patients with cirrhosis of liver: an experience from a tertiary care center in northern India","volume":"26","author":"Paul","year":"2007","journal-title":"Indian J Gastroenterol"},{"issue":"1","key":"10.1016\/j.jceh.2014.04.003_bib8","first-page":"97","article-title":"Trends in cancer incidence in esophagus, stomach, colon, rectum and liver in males in India","volume":"9","author":"Yeole","year":"2008","journal-title":"Asian Pac J Cancer Prev"},{"issue":"6","key":"10.1016\/j.jceh.2014.04.003_bib9","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/cld.111","article-title":"Risk factors for hepatocellular carcinoma","volume":"1","author":"Herbst","year":"2012","journal-title":"Clin Liver Dis"},{"issue":"1","key":"10.1016\/j.jceh.2014.04.003_bib10","first-page":"1","article-title":"Hepatocellular carcinoma\u2014a model of human cancer: clinico-pathological features, etiology and pathogenesis","volume":"46","author":"Nayak","year":"2003","journal-title":"Indian J Pathol Microbiol"},{"issue":"12","key":"10.1016\/j.jceh.2014.04.003_bib11","doi-asserted-by":"crossref","first-page":"e27326","DOI":"10.1371\/journal.pone.0027326","article-title":"The role of pre-existing diabetes mellitus on hepatocellular carcinoma occurrence and prognosis: a meta-analysis of prospective cohort studies","volume":"6","author":"Yang","year":"2011","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.jceh.2014.04.003_bib12","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/dmrr.1291","article-title":"Diabetes mellitus and risk of hepatocellular carcinoma: a systematic review and meta-analysis","volume":"28","author":"Wang","year":"2012","journal-title":"Diabetes Metab Res Rev"},{"issue":"7","key":"10.1016\/j.jceh.2014.04.003_bib13","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1002\/ijc.26165","article-title":"Increased risk of hepatocellular carcinoma in patients with diabetes mellitus: a systematic review and meta-analysis of cohort studies","volume":"130","author":"Wang","year":"2012","journal-title":"Int J Cancer"},{"issue":"4","key":"10.1016\/j.jceh.2014.04.003_bib14","first-page":"334","article-title":"Hepatitis B surface antigen, hepatocellular carcinoma and cirrhosis in south India\u2014an autopsy study","volume":"33","author":"Sundaram","year":"1990","journal-title":"Indian J Pathol Microbiol"},{"issue":"4","key":"10.1016\/j.jceh.2014.04.003_bib15","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1440-1746.1992.tb01006.x","article-title":"Prevalence of hepatitis C virus antibodies in chronic liver disease and hepatocellular carcinoma patients in India","volume":"7","author":"Ramesh","year":"1992","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.jceh.2014.04.003_bib16","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1046\/j.1440-1746.2001.02476.x","article-title":"Profile of hepatocellular carcinoma in India: an insight into the possible etiologic associations","volume":"16","author":"Sarin","year":"2001","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"1\u20132","key":"10.1016\/j.jceh.2014.04.003_bib17","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.cca.2006.02.038","article-title":"Evaluation of clinical and biochemical parameters in hepatocellular carcinoma: experience from an Indian center","volume":"371","author":"Saini","year":"2006","journal-title":"Clin Chim Acta"},{"issue":"7","key":"10.1016\/j.jceh.2014.04.003_bib18","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1111\/j.1440-1746.2007.04908.x","article-title":"Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India","volume":"22","author":"Kumar","year":"2007","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"Pt 11","key":"10.1016\/j.jceh.2014.04.003_bib19","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1099\/jmm.0.47151-0","article-title":"Prevalence of aflatoxin B1 in liver biopsies of proven hepatocellular carcinoma in India determined by an in-house immunoperoxidase test","volume":"56","author":"Murugavel","year":"2007","journal-title":"J\u00a0Med Microbiol"},{"issue":"6","key":"10.1016\/j.jceh.2014.04.003_bib20","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1093\/qjmed\/hcn033","article-title":"Characteristics of hepatocellular carcinoma in India: a retrospective analysis of 191 cases","volume":"101","author":"Kumar","year":"2008","journal-title":"QJM"},{"issue":"3\u20134","key":"10.1016\/j.jceh.2014.04.003_bib21","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1159\/000231886","article-title":"Clinical profile, etiology and therapeutic outcome in 324 hepatocellular carcinoma patients at a tertiary care center in India","volume":"77","author":"Paul","year":"2009","journal-title":"Oncology"},{"issue":"14\u201315","key":"10.1016\/j.jceh.2014.04.003_bib22","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.clinbiochem.2011.07.017","article-title":"Role of aflatoxin B1 as a risk for primary liver cancer in north Indian population","volume":"44","author":"Asim","year":"2011","journal-title":"Clin Biochem"},{"issue":"7","key":"10.1016\/j.jceh.2014.04.003_bib23","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1002\/jmv.23290","article-title":"Hepatitis C virus related hepatocellular carcinoma: a case control study from India","volume":"84","author":"Sarma","year":"2012","journal-title":"J\u00a0Med Virol"},{"issue":"7","key":"10.1016\/j.jceh.2014.04.003_bib24","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1097\/MEG.0b013e3283534b40","article-title":"Hepatocellular carcinoma in nonalcoholic fatty liver cirrhosis and alcoholic cirrhosis: risk factor analysis in liver transplant recipients","volume":"24","author":"Jain","year":"2012","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"10","key":"10.1016\/j.jceh.2014.04.003_bib25","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1097\/MEG.0b013e32835643f1","article-title":"Etiologic types of end-stage chronic liver disease in adults: analysis of prevalence and their temporal changes from a study on native liver explants","volume":"24","author":"Nayak","year":"2012","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.jceh.2014.04.003_bib26","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/ijc.27993","article-title":"Etiological and molecular profile of hepatocellular cancer from India","volume":"133","author":"Asim","year":"2013","journal-title":"Int J Cancer"},{"issue":"6","key":"10.1016\/j.jceh.2014.04.003_bib27","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1002\/hep.23838","article-title":"Nonalcoholic fatty liver in a developing country is responsible for significant liver disease","volume":"52","author":"Duseja","year":"2010","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.jceh.2014.04.003_bib28","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S1665-2681(19)31871-X","article-title":"Impact of diabetes mellitus on outcome of HCC","volume":"7","author":"Amarapurkar","year":"2008","journal-title":"Ann Hepatol"},{"issue":"1","key":"10.1016\/j.jceh.2014.04.003_bib29","first-page":"3","article-title":"Chronic liver disease in diabetes mellitus","volume":"23","author":"Amarapurkar","year":"2002","journal-title":"Trop Gastroenterol"},{"issue":"6","key":"10.1016\/j.jceh.2014.04.003_bib30","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1155\/2010\/328408","article-title":"Genetic polymorphism of glutathione S transferases M1 and T1 in Indian patients with hepatocellular carcinoma","volume":"28","author":"Asim","year":"2010","journal-title":"Dis Markers"},{"issue":"1\u20132","key":"10.1016\/j.jceh.2014.04.003_bib31","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s10555-012-9412-6","article-title":"Tackling hepatitis B virus-associated hepatocellular carcinoma \u2013 the future is now","volume":"32","author":"Bharadwaj","year":"2013","journal-title":"Cancer Metastasis Rev."},{"issue":"1","key":"10.1016\/j.jceh.2014.04.003_bib32","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/cncr.10954","article-title":"Surface, core, and X genes of hepatitis B virus in hepatocellular carcinoma: an in situ hybridization study","volume":"99","author":"Jayshree","year":"2003","journal-title":"Cancer"},{"issue":"Pt 2","key":"10.1016\/j.jceh.2014.04.003_bib33","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1099\/0022-1317-75-2-327","article-title":"Mapping of the hepatitis B virus genome in hepatocellular carcinoma using PCR and demonstration of a potential trans-activator encoded by the frequently detected fragment","volume":"75","author":"Ramesh","year":"1994","journal-title":"J\u00a0Gen Virol"},{"issue":"7","key":"10.1016\/j.jceh.2014.04.003_bib34","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1002\/jmv.21774","article-title":"Hepatitis B virus BCP, precore\/core, X gene mutations\/genotypes and the risk of hepatocellular carcinoma in India","volume":"82","author":"Asim","year":"2010","journal-title":"J\u00a0Med Virol"},{"issue":"2","key":"10.1016\/j.jceh.2014.04.003_bib35","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.cancergencyto.2009.06.021","article-title":"Methylation profiling of tumor suppressor genes and oncogenes in hepatitis virus-related hepatocellular carcinoma in northern India","volume":"195","author":"Kiran","year":"2009","journal-title":"Cancer Genet Cytogenet"},{"issue":"8","key":"10.1016\/j.jceh.2014.04.003_bib36","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1111\/j.1478-3231.2009.02082.x","article-title":"Telomerase activity, telomere length and human telomerase reverse transcriptase expression in hepatocellular carcinoma is independent of hepatitis virus status","volume":"29","author":"Saini","year":"2009","journal-title":"Liver Int"},{"issue":"4","key":"10.1016\/j.jceh.2014.04.003_bib37","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1053\/j.gastro.2012.02.024","article-title":"Predictive scores for hepatocellular carcinoma development in chronic hepatitis B virus infection: \u201cdoes one size fit all?\u201d","volume":"142","author":"Sarin","year":"2012","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.jceh.2014.04.003_bib38","first-page":"549","article-title":"Hepatitis C virus (HCV)\u2014a review molecular biology of the virus, immunodiagnostics, genomic heterogeneity and the role of virus in hepatocellular carcinoma","volume":"41","author":"Poduri","year":"2003","journal-title":"Indian J Exp Biol"},{"issue":"12","key":"10.1016\/j.jceh.2014.04.003_bib39","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1089\/dna.2008.0805","article-title":"Glutathione-S-transferase and microsomal epoxide hydrolase polymorphism and viral-related hepatocellular carcinoma risk in India","volume":"27","author":"Kiran","year":"2008","journal-title":"DNA Cell Biol"},{"issue":"7","key":"10.1016\/j.jceh.2014.04.003_bib40","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1002\/(SICI)1097-0142(20000401)88:7<1565::AID-CNCR10>3.0.CO;2-9","article-title":"P53 tumor suppressor gene mutations in hepatocellular carcinoma patients in India","volume":"88","author":"Katiyar","year":"2000","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.jceh.2014.04.003_bib41","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s10620-012-2409-8","article-title":"Analysis of genetic damage and gene polymorphism in hepatocellular carcinoma (HCC) patients in a South Indian population","volume":"58","author":"Mohana Devi","year":"2013","journal-title":"Dig Dis Sci."},{"issue":"1\u20132","key":"10.1016\/j.jceh.2014.04.003_bib42","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s11010-009-0035-3","article-title":"Polymorphism of DNA repair gene XRCC1 and hepatitis-related hepatocellular carcinoma risk in Indian population","volume":"327","author":"Kiran","year":"2009","journal-title":"Mol Cell Biochem"},{"issue":"11","key":"10.1016\/j.jceh.2014.04.003_bib43","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1089\/dna.2009.0921","article-title":"Haplotypes of microsomal epoxide hydrolase and X-ray cross-complementing group 1 genes in Indian hepatocellular carcinoma patients","volume":"28","author":"Kiran","year":"2009","journal-title":"DNA Cell Biol"},{"issue":"2","key":"10.1016\/j.jceh.2014.04.003_bib44","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s12072-008-9054-5","article-title":"Economic evaluation of a surveillance program of hepatocellular carcinoma (HCC) in India","volume":"2","author":"Paul","year":"2008","journal-title":"Hepatol Int"},{"issue":"26","key":"10.1016\/j.jceh.2014.04.003_bib45","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1056\/NEJM199706263362602","article-title":"Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group","volume":"336","author":"Chang","year":"1997","journal-title":"N\u00a0Engl J Med"},{"issue":"15","key":"10.1016\/j.jceh.2014.04.003_bib46","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1056\/NEJMoa033364","article-title":"Lamivudine for patients with chronic hepatitis B and advanced liver disease","volume":"351","author":"Liaw","year":"2004","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.jceh.2014.04.003_bib47","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/hep.25937","article-title":"Prevention of hepatitis B virus-related hepatocellular carcinoma with antiviral therapy","volume":"57","author":"Lai","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2014.04.003_bib48","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jtbi.2012.03.030","article-title":"Modelling hepatitis C virus infection and the development of hepatocellular carcinoma","volume":"305","author":"Chakrabarty","year":"2012","journal-title":"J\u00a0Theor Biol"},{"issue":"3","key":"10.1016\/j.jceh.2014.04.003_bib49","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.cgh.2009.11.018","article-title":"A\u00a0sustained viral response is associated with reduced liver-related morbidity and mortality in patients with hepatitis C virus","volume":"8","author":"Singal","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.jceh.2014.04.003_bib50","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.cgh.2009.10.026","article-title":"Antiviral therapy reduces risk of hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis","volume":"8","author":"Singal","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"23","key":"10.1016\/j.jceh.2014.04.003_bib51","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1056\/NEJMoa0707615","article-title":"Prolonged therapy of advanced chronic hepatitis C with low-dose peginterferon","volume":"359","author":"Di Bisceglie","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"5 Pt 1","key":"10.1016\/j.jceh.2014.04.003_bib52","doi-asserted-by":"crossref","first-page":"329","DOI":"10.7326\/0003-4819-158-5-201303050-00005","article-title":"Eradication of hepatitis C virus infection and the development of hepatocellular carcinoma: a meta-analysis of observational studies","volume":"158","author":"Morgan","year":"2013","journal-title":"Ann Intern Med"},{"issue":"suppl 1","key":"10.1016\/j.jceh.2014.04.003_bib53","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1016\/S0168-8278(12)60009-9","article-title":"Management of HCC","volume":"56","author":"De Lope","year":"2012","journal-title":"J\u00a0Hepatol"},{"issue":"9399","key":"10.1016\/j.jceh.2014.04.003_bib54","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/S0140-6736(03)14964-1","article-title":"Hepatocellular carcinoma","volume":"362","author":"Llovet","year":"2003","journal-title":"Lancet"},{"issue":"9822","key":"10.1016\/j.jceh.2014.04.003_bib55","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0140-6736(11)61347-0","article-title":"Hepatocellular carcinoma","volume":"379","author":"Forner","year":"2012","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.jceh.2014.04.003_bib56","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1007\/s10620-012-2413-z","article-title":"Surveillance for hepatocellular carcinoma: long way to achieve effectiveness","volume":"57","author":"El-Serag","year":"2012","journal-title":"Dig Dis Sci"},{"issue":"3","key":"10.1016\/j.jceh.2014.04.003_bib57","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1053\/j.seminoncol.2010.05.006","article-title":"Principles of cancer screening: lessons from history and study design issues","volume":"37","author":"Croswell","year":"2010","journal-title":"Semin Oncol"},{"issue":"7","key":"10.1016\/j.jceh.2014.04.003_bib58","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00432-004-0552-0","article-title":"Randomized controlled trial of screening for hepatocellular carcinoma","volume":"130","author":"Zhang","year":"2004","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"key":"10.1016\/j.jceh.2014.04.003_bib59","first-page":"CD002799","article-title":"Alpha-foetoprotein and\/or liver ultrasonography for screening of hepatocellular carcinoma in patients with chronic hepatitis B","volume":"9","author":"Aghoram","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"10.1016\/j.jceh.2014.04.003_bib60","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1111\/j.1572-0241.2004.30137.x","article-title":"Surveillance for hepatocellular carcinoma in elderly Italian patients with cirrhosis: effects on cancer staging and patient survival","volume":"99","author":"Trevisani","year":"2004","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.jceh.2014.04.003_bib61","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/hep.510310211","article-title":"Early detection of hepatocellular carcinoma increases the chance of treatment: Hong Kong experience","volume":"31","author":"Yuen","year":"2000","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.jceh.2014.04.003_bib62","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1053\/lv.2000.4875","article-title":"Improved survival with screening for hepatocellular carcinoma","volume":"6","author":"Wong","year":"2000","journal-title":"Liver Transpl"},{"issue":"4","key":"10.1016\/j.jceh.2014.04.003_bib63","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1053\/j.gastro.2003.12.049","article-title":"Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance","volume":"126","author":"Sangiovanni","year":"2004","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.jceh.2014.04.003_bib64","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1111\/j.1572-0241.2007.01395.x","article-title":"Surveillance for early diagnosis of hepatocellular carcinoma: is it effective in intermediate\/advanced cirrhosis?","volume":"102","author":"Trevisani","year":"2007","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.jceh.2014.04.003_bib65","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/j.1572-0241.2002.05557.x","article-title":"Semiannual and annual surveillance of cirrhotic patients for hepatocellular carcinoma: effects on cancer stage and patient survival (Italian experience)","volume":"97","author":"Trevisani","year":"2002","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.jceh.2014.04.003_bib66","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S0002-9343(96)00197-0","article-title":"Cost-effectiveness of screening for detection of small hepatocellular carcinoma in western patients with Child\u2013Pugh class A cirrhosis","volume":"101","author":"Sarasin","year":"1996","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.jceh.2014.04.003_bib67","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/j.1572-0241.2003.07327.x","article-title":"Screening for hepatocellular carcinoma in patients with hepatitis C cirrhosis: a cost-utility analysis","volume":"98","author":"Arguedas","year":"2003","journal-title":"Am J Gastroenterol"},{"issue":"11","key":"10.1016\/j.jceh.2014.04.003_bib68","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1111\/j.1365-2036.2004.01963.x","article-title":"Cost-effectiveness of screening for hepatocellular carcinoma in patients with cirrhosis due to chronic hepatitis C","volume":"19","author":"Lin","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jceh.2014.04.003_bib69","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2147\/RMHP.S18677","article-title":"Hepatocellular carcinoma: cost-effectiveness of screening. A systematic review","volume":"5","author":"Ruggeri","year":"2012","journal-title":"Risk Manag Healthc Policy"},{"issue":"6","key":"10.1016\/j.jceh.2014.04.003_bib70","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1111\/j.1440-1746.2009.05805.x","article-title":"Application of surveillance programs for hepatocellular carcinoma in the Asia\u2013Pacific Region","volume":"24","author":"Amarapurkar","year":"2009","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"12","key":"10.1016\/j.jceh.2014.04.003_bib71","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.cgh.2012.10.001","article-title":"Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review","volume":"10","author":"White","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.jceh.2014.04.003_bib72","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1365-2036.2009.04014.x","article-title":"Meta-analysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis","volume":"30","author":"Singal","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.jceh.2014.04.003_bib73","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0016-5085(85)90324-5","article-title":"Growth rate of asymptomatic hepatocellular carcinoma and its clinical implications","volume":"89","author":"Sheu","year":"1985","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.jceh.2014.04.003_bib74","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1002\/hep.24545","article-title":"Ultrasonographic surveillance of hepatocellular carcinoma in cirrhosis: a randomized trial\u00a0comparing 3- and 6-month periodicities","volume":"54","author":"Trinchet","year":"2011","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.jceh.2014.04.003_bib75","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1097\/MCG.0b013e3182755c13","article-title":"Survival of hepatocellular carcinoma patients may be improved in surveillance interval not more than 6 months compared with more than 6 months: a 15-year prospective study","volume":"47","author":"Han","year":"2013","journal-title":"J Clin Gastroenterol"},{"issue":"4","key":"10.1016\/j.jceh.2014.04.003_bib76","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/S0168-8278(00)00053-2","article-title":"Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status","volume":"34","author":"Trevisani","year":"2001","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.jceh.2014.04.003_bib77","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1053\/j.gastro.2009.04.005","article-title":"Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma","volume":"137","author":"Marrero","year":"2009","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.jceh.2014.04.003_bib78","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1053\/j.gastro.2009.10.031","article-title":"Des-gamma-carboxy prothrombin and alpha-fetoprotein as biomarkers for the early detection of hepatocellular carcinoma","volume":"138","author":"Lok","year":"2010","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.jceh.2014.04.003_bib79","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jhep.2005.03.019","article-title":"Serum alpha-fetoprotein levels in patients with advanced hepatitis C: results from the HALT-C Trial","volume":"43","author":"Di Bisceglie","year":"2005","journal-title":"J\u00a0Hepatol"},{"issue":"25","key":"10.1016\/j.jceh.2014.04.003_bib80","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1056\/NEJM199306243282501","article-title":"Risk factors for hepatocellular carcinoma among patients with chronic liver disease","volume":"328","author":"Tsukuma","year":"1993","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.jceh.2014.04.003_bib81","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1007\/s00432-009-0547-y","article-title":"Intrahepatic cholangiocarcinoma: report of 272 patients compared with 5,829 patients with hepatocellular carcinoma","volume":"135","author":"Zhou","year":"2009","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"issue":"suppl 1","key":"10.1016\/j.jceh.2014.04.003_bib82","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1159\/000111717","article-title":"Evaluating patients with cirrhosis for hepatocellular carcinoma: value of clinical symptomatology, imaging and alpha-fetoprotein","volume":"72","author":"Paul","year":"2007","journal-title":"Oncology"},{"issue":"3","key":"10.1016\/j.jceh.2014.04.003_bib83","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1159\/000327577","article-title":"Management of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version","volume":"29","author":"Kudo","year":"2011","journal-title":"Dig Dis"},{"issue":"3","key":"10.1016\/j.jceh.2014.04.003_bib84","doi-asserted-by":"crossref","first-page":"213","DOI":"10.4103\/TROG_20103103_213","article-title":"Evaluation of hepatocellular carcinoma by contrast enhanced ultrasound: a novel technique","volume":"31","author":"Paul","year":"2010","journal-title":"Trop Gastroenterol"},{"issue":"suppl 1","key":"10.1016\/j.jceh.2014.04.003_bib85","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000122600","article-title":"Differential diagnosis of hepatic tumors: value of contrast-enhanced harmonic sonography using the newly developed contrast agent, Sonazoid","volume":"51","author":"Hatanaka","year":"2008","journal-title":"Intervirology"},{"issue":"3","key":"10.1016\/j.jceh.2014.04.003_bib86","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1572-0241.2006.00467.x","article-title":"Accuracy of ultrasonography, spiral CT, magnetic resonance, and alpha-fetoprotein in diagnosing hepatocellular carcinoma: a systematic review","volume":"101","author":"Colli","year":"2006","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.jceh.2014.04.003_bib87","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/hep.21966","article-title":"Diagnosis of hepatic nodules 20\u00a0mm or smaller in cirrhosis: prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma","volume":"47","author":"Forner","year":"2008","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.jceh.2014.04.003_bib88","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1136\/gut.2009.187286","article-title":"The diagnostic and economic impact of contrast imaging techniques in the diagnosis of small hepatocellular carcinoma in cirrhosis","volume":"59","author":"Sangiovanni","year":"2010","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.jceh.2014.04.003_bib89","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.jhep.2010.07.025","article-title":"Optimization of imaging diagnosis of 1\u20132\u00a0cm hepatocellular carcinoma: an analysis of diagnostic performance and resource utilization","volume":"54","author":"Khalili","year":"2011","journal-title":"J\u00a0Hepatol"},{"issue":"4","key":"10.1016\/j.jceh.2014.04.003_bib90","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S0899-7071(02)00438-2","article-title":"Spectrum of hepatocellular carcinoma on triple phase helical CT: a pictorial essay","volume":"26","author":"Paul","year":"2002","journal-title":"Clin Imaging"},{"issue":"1","key":"10.1016\/j.jceh.2014.04.003_bib91","first-page":"21","article-title":"Hepatocellular carcinoma\u2013image morphology in 40 patients","volume":"13","author":"Karak","year":"1992","journal-title":"Trop Gastroenterol"},{"key":"10.1016\/j.jceh.2014.04.003_bib92","first-page":"424","article-title":"Laparoscopic & histological features of hepatocellular carcinoma","volume":"94","author":"Bhargava","year":"1991","journal-title":"Indian J Med Res"},{"issue":"2","key":"10.1016\/j.jceh.2014.04.003_bib93","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/PAI.0b013e31825d527f","article-title":"Utility of an immunohistochemical panel consisting of Glypican-3, heat-shock protein-70, and glutamine synthetase in the distinction of low-grade hepatocellular carcinoma from hepatocellular adenoma","volume":"21","author":"Lagana","year":"2013","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"4","key":"10.1016\/j.jceh.2014.04.003_bib94","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1365-2303.2007.00520.x","article-title":"Role of CD10 immunochemistry in differentiating hepatocellular carcinoma from metastatic carcinoma of the liver","volume":"19","author":"Ahuja","year":"2008","journal-title":"Cytopathology"},{"issue":"4","key":"10.1016\/j.jceh.2014.04.003_bib95","first-page":"178","article-title":"Value of ultrasonography-guided fine needle aspiration cytology in the investigative sequence of hepatic lesions with an emphasis on hepatocellular carcinoma","volume":"28","author":"Swamy","year":"2011","journal-title":"J\u00a0Cytol"},{"issue":"6","key":"10.1016\/j.jceh.2014.04.003_bib96","first-page":"447","article-title":"Clinical relevance of alphafetoprotein microheterogeneity in alphafetoprotein-secreting tumors","volume":"18","author":"Saraswathi","year":"1994","journal-title":"Cancer Detect Prev"},{"issue":"2","key":"10.1016\/j.jceh.2014.04.003_bib97","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0009-8981(88)90253-7","article-title":"Diagnostic significance of estimation of serum apolipoprotein A along with alpha-fetoprotein in alcoholic cirrhosis and hepatocellular carcinoma patients","volume":"173","author":"Nayak","year":"1988","journal-title":"Clin Chim Acta"},{"issue":"6","key":"10.1016\/j.jceh.2014.04.003_bib98","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1016\/j.ijid.2008.04.010","article-title":"Alpha-fetoprotein as a tumor marker in hepatocellular carcinoma: investigations in south Indian subjects with hepatotropic virus and aflatoxin etiologies","volume":"12","author":"Murugavel","year":"2008","journal-title":"Int J Infect Dis"},{"issue":"1","key":"10.1016\/j.jceh.2014.04.003_bib99","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jhep.2012.08.022","article-title":"Established and novel imaging biomarkers for assessing response to therapy in hepatocellular carcinoma","volume":"58","author":"Jiang","year":"2013","journal-title":"J\u00a0Hepatol"},{"issue":"11","key":"10.1016\/j.jceh.2014.04.003_bib100","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.2967\/jnumed.110.075507","article-title":"Detection of hepatocellular carcinoma with PET\/CT: a prospective comparison of 18F-fluorocholine and 18F-FDG in patients with cirrhosis or chronic liver disease","volume":"51","author":"Talbot","year":"2010","journal-title":"J\u00a0Nucl Med"},{"issue":"suppl 2","key":"10.1016\/j.jceh.2014.04.003_bib101","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1002\/lt.22352","article-title":"What is the best staging system for hepatocellular carcinoma in the setting of liver transplantation?","volume":"17","author":"Olthoff","year":"2011","journal-title":"Liver Transpl"},{"issue":"3","key":"10.1016\/j.jceh.2014.04.003_bib102","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1055\/s-2007-1007122","article-title":"Prognosis of hepatocellular carcinoma: the BCLC staging classification","volume":"19","author":"Llovet","year":"1999","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jceh.2014.04.003_bib103","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/cld.129","article-title":"Natural history and staging for hepatocellular carcinoma","volume":"1","author":"Forner","year":"2012","journal-title":"Clin Liver Dis"},{"issue":"4","key":"10.1016\/j.jceh.2014.04.003_bib104","first-page":"271","article-title":"Comparison of 7 staging systems in north Indian cohort of hepatocellular carcinoma","volume":"31","author":"Sarma","year":"2010","journal-title":"Trop Gastroenterol"},{"issue":"6","key":"10.1016\/j.jceh.2014.04.003_bib105","doi-asserted-by":"crossref","first-page":"902","DOI":"10.2967\/jnumed.106.036673","article-title":"Dual-tracer PET\/CT imaging in evaluation of metastatic hepatocellular carcinoma","volume":"48","author":"Ho","year":"2007","journal-title":"J\u00a0Nucl Med"},{"issue":"4","key":"10.1016\/j.jceh.2014.04.003_bib106","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s005340170004","article-title":"Current status of surgery and transplantation in the management of hepatocellular carcinoma: an overview","volume":"8","author":"Pal","year":"2001","journal-title":"J\u00a0Hepatobiliary Pancreat Surg"},{"issue":"suppl 2","key":"10.1016\/j.jceh.2014.04.003_bib107","doi-asserted-by":"crossref","first-page":"ii27","DOI":"10.1093\/annonc\/mdn114","article-title":"Hepatocellular carcinoma: ESMO clinical recommendations for diagnosis, treatment and follow-up","volume":"19","author":"Parikh","year":"2008","journal-title":"Ann Oncol"},{"issue":"6","key":"10.1016\/j.jceh.2014.04.003_bib108","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1002\/hep.510300629","article-title":"Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation","volume":"30","author":"Llovet","year":"1999","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.jceh.2014.04.003_bib109","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1055\/s-2005-871198","article-title":"Resection and liver transplantation for hepatocellular carcinoma","volume":"25","author":"Llovet","year":"2005","journal-title":"Semin Liver Dis"},{"issue":"3","key":"10.1016\/j.jceh.2014.04.003_bib110","doi-asserted-by":"crossref","first-page":"154","DOI":"10.4103\/0973-1482.57119","article-title":"Surgery for malignant liver tumors","volume":"5","author":"Shukla","year":"2009","journal-title":"J\u00a0Cancer Res Ther"},{"issue":"1","key":"10.1016\/j.jceh.2014.04.003_bib111","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1080\/13651820600985259","article-title":"Two hundred and forty-one consecutive liver resections: an experience from India","volume":"9","author":"Marwah","year":"2007","journal-title":"HPB (Oxford)"},{"issue":"6","key":"10.1016\/j.jceh.2014.04.003_bib112","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1053\/jhep.2001.24563","article-title":"Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival","volume":"33","author":"Yao","year":"2001","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.jceh.2014.04.003_bib113","doi-asserted-by":"crossref","first-page":"e48932","DOI":"10.1371\/journal.pone.0048932","article-title":"Salvage liver transplantation for recurrent hepatocellular carcinoma within UCSF criteria after liver resection","volume":"7","author":"Liu","year":"2012","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.jceh.2014.04.003_bib114","doi-asserted-by":"crossref","first-page":"174","DOI":"10.5144\/0256-4947.2012.174","article-title":"Saudi guidelines for the\u00a0diagnosis and management of hepatocellular carcinoma: technical review and practice guidelines","volume":"32","author":"Abdo","year":"2012","journal-title":"Ann Saudi Med"},{"issue":"4","key":"10.1016\/j.jceh.2014.04.003_bib115","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jhep.2011.12.001","article-title":"EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma","volume":"56","year":"2012","journal-title":"J\u00a0Hepatol"},{"issue":"11","key":"10.1016\/j.jceh.2014.04.003_bib116","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJM199603143341104","article-title":"Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis","volume":"334","author":"Mazzaferro","year":"1996","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.jceh.2014.04.003_bib117","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1053\/jhep.2001.23561","article-title":"Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis","volume":"33","author":"Jonas","year":"2001","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.jceh.2014.04.003_bib118","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1053\/j.gastro.2005.03.033","article-title":"Liver transplantation for hepatocellular carcinoma","volume":"128","author":"Befeler","year":"2005","journal-title":"Gastroenterology"},{"issue":"suppl 2","key":"10.1016\/j.jceh.2014.04.003_bib119","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1002\/lt.22365","article-title":"Milan criteria in liver transplantation for hepatocellular carcinoma: an evidence-based analysis of 15 years of experience","volume":"17","author":"Mazzaferro","year":"2011","journal-title":"Liver Transpl"},{"issue":"3","key":"10.1016\/j.jceh.2014.04.003_bib120","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1007\/s12072-011-9318-3","article-title":"Survival advantage of primary liver transplantation for hepatocellular carcinoma within the up-to-7 criteria with microvascular invasion","volume":"6","author":"Chan","year":"2012","journal-title":"Hepatol Int"},{"issue":"11","key":"10.1016\/j.jceh.2014.04.003_bib121","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.1477-2574.2011.00355.x","article-title":"Which is more cost-effective under the MELD system: primary liver transplantation, or salvage transplantation after hepatic resection or after loco-regional therapy for hepatocellular carcinoma within Milan criteria?","volume":"13","author":"Landman","year":"2011","journal-title":"HPB (Oxford)"},{"issue":"1","key":"10.1016\/j.jceh.2014.04.003_bib122","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/S1470-2045(11)70175-9","article-title":"Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report","volume":"13","author":"Clavien","year":"2012","journal-title":"Lancet Oncol"},{"issue":"11","key":"10.1016\/j.jceh.2014.04.003_bib123","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1111\/j.1600-6143.2007.01965.x","article-title":"Liver transplantation for hepatocellular carcinoma: validation of the UCSF-expanded criteria based on preoperative imaging","volume":"7","author":"Yao","year":"2007","journal-title":"Am J Transplant"},{"issue":"4","key":"10.1016\/j.jceh.2014.04.003_bib124","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1111\/j.1600-6143.2007.02138.x","article-title":"A\u00a0novel model measuring the harm of transplanting hepatocellular carcinoma exceeding Milan criteria","volume":"8","author":"Volk","year":"2008","journal-title":"Am J Transplant"},{"issue":"1","key":"10.1016\/j.jceh.2014.04.003_bib125","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1136\/gut.50.1.123","article-title":"Cost effectiveness of adjuvant therapy for hepatocellular carcinoma during the waiting list for liver transplantation","volume":"50","author":"Llovet","year":"2002","journal-title":"Gut"},{"issue":"11 suppl 2","key":"10.1016\/j.jceh.2014.04.003_bib126","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1002\/lt.21328","article-title":"Management of hepatocellular carcinoma on the waiting list before liver transplantation: time for controlled trials?","volume":"13","author":"Majno","year":"2007","journal-title":"Liver Transpl"},{"issue":"3 suppl l","key":"10.1016\/j.jceh.2014.04.003_bib127","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1097\/01.TP.0000047029.02806.16","article-title":"Living-donor liver transplantation for hepatocellular carcinoma","volume":"75","author":"Kaihara","year":"2003","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.jceh.2014.04.003_bib128","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/01.sla.0000137129.98894.42","article-title":"Living donor liver transplantation for adult patients with hepatocellular carcinoma: experience in Japan","volume":"240","author":"Todo","year":"2004","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.jceh.2014.04.003_bib129","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s12262-011-0385-4","article-title":"Donor safety in live-related liver transplantation","volume":"74","author":"Wakade","year":"2012","journal-title":"Indian J Surg"},{"issue":"1","key":"10.1016\/j.jceh.2014.04.003_bib130","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s12262-011-0387-2","article-title":"Liver transplantation for HCC: a review","volume":"74","author":"Kakodkar","year":"2012","journal-title":"Indian J Surg"},{"issue":"2","key":"10.1016\/j.jceh.2014.04.003_bib131","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.transproceed.2012.01.043","article-title":"Hepatocellular carcinoma downstaging in liver transplantation","volume":"44","author":"Yu","year":"2012","journal-title":"Transplant Proc"},{"issue":"2","key":"10.1016\/j.jceh.2014.04.003_bib132","doi-asserted-by":"crossref","first-page":"E125","DOI":"10.1111\/j.1399-0012.2011.01572.x","article-title":"Combination of biological and morphological parameters for the selection of patients with hepatocellular carcinoma waiting for liver transplantation","volume":"26","author":"Lai","year":"2012","journal-title":"Clin Transplant"},{"issue":"3","key":"10.1016\/j.jceh.2014.04.003_bib133","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1002\/hep.22693","article-title":"Reassessing selection criteria prior to liver transplantation for hepatocellular carcinoma utilizing the Scientific Registry of Transplant Recipients Database","volume":"49","author":"Toso","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2014.04.003_bib134","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2036.2012.05060.x","article-title":"Systematic review: the prognostic role of alpha-fetoprotein following liver transplant for hepatocellular carcinoma","author":"Hakeem","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.jceh.2014.04.003_bib135","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s12262-011-0377-4","article-title":"Interventional radiological treatment of hepatocellular carcinoma: an update","volume":"74","author":"Shrimal","year":"2012","journal-title":"Indian J Surg"},{"issue":"6","key":"10.1016\/j.jceh.2014.04.003_bib136","first-page":"347","article-title":"Percutaneous ablative therapy for hepatocellular carcinoma","volume":"24","author":"Paul","year":"2011","journal-title":"Natl Med J India"},{"issue":"6","key":"10.1016\/j.jceh.2014.04.003_bib137","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1002\/hep.20465","article-title":"Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma","volume":"40","author":"Sala","year":"2004","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.jceh.2014.04.003_bib138","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/hep.23725","article-title":"Loco-regional treatment of hepatocellular carcinoma","volume":"52","author":"Lencioni","year":"2010","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.jceh.2014.04.003_bib139","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1002\/1097-0142(19920215)69:4<925::AID-CNCR2820690415>3.0.CO;2-G","article-title":"Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis. A study on 207 patients","volume":"69","author":"Livraghi","year":"1992","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.jceh.2014.04.003_bib140","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1002\/1097-0142(19951115)76:10<1737::AID-CNCR2820761010>3.0.CO;2-P","article-title":"Treatment of small hepatocellular carcinoma with percutaneous ethanol injection. Analysis of prognostic factors in 105 western patients","volume":"76","author":"Lencioni","year":"1995","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.jceh.2014.04.003_bib141","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1148\/radiology.197.1.7568806","article-title":"Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection","volume":"197","author":"Livraghi","year":"1995","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.jceh.2014.04.003_bib142","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0168-8278(00)80072-0","article-title":"Prospective analysis of risk factors for early intrahepatic recurrence of hepatocellular carcinoma following ethanol injection","volume":"32","author":"Khan","year":"2000","journal-title":"J\u00a0Hepatol"},{"issue":"7","key":"10.1016\/j.jceh.2014.04.003_bib143","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1080\/00365520310003048","article-title":"Comparison of percutaneous acetic acid injection and percutaneous ethanol injection for hepatocellular carcinoma in cirrhotic patients: a prospective study","volume":"38","author":"Huo","year":"2003","journal-title":"Scand J Gastroenterol"},{"issue":"3","key":"10.1016\/j.jceh.2014.04.003_bib144","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1148\/radiol.2343040350","article-title":"Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation","volume":"234","author":"Lencioni","year":"2005","journal-title":"Radiology"},{"issue":"5 suppl 1","key":"10.1016\/j.jceh.2014.04.003_bib145","doi-asserted-by":"crossref","first-page":"S159","DOI":"10.1053\/j.gastro.2004.09.030","article-title":"Treatment of hepatocellular carcinoma by percutaneous tumor ablation methods: ethanol injection therapy and radiofrequency ablation","volume":"127","author":"Omata","year":"2004","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.jceh.2014.04.003_bib146","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1002\/hep.23181","article-title":"Radiofrequency ablation of hepatocellular carcinoma: long-term results and prognostic factors in 235 western patients with cirrhosis","volume":"50","author":"N'Kontchou","year":"2009","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.jceh.2014.04.003_bib147","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/hep.22648","article-title":"Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies","volume":"49","author":"Cho","year":"2009","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.jceh.2014.04.003_bib148","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jhep.2009.12.004","article-title":"Clinical outcomes of radiofrequency ablation, percutaneous alcohol and acetic acid injection for hepatocellular carcinoma: a meta-analysis","volume":"52","author":"Germani","year":"2010","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2014.04.003_bib149","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1471-230X-9-31","article-title":"Meta-analysis of percutaneous radiofrequency ablation versus ethanol injection in hepatocellular carcinoma","volume":"9","author":"Bouza","year":"2009","journal-title":"BMC Gastroenterol"},{"issue":"2","key":"10.1016\/j.jceh.2014.04.003_bib150","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/ajg.2008.80","article-title":"Radiofrequency thermal ablation vs. percutaneous ethanol injection for small hepatocellular carcinoma in cirrhosis: meta-analysis of randomized controlled trials","volume":"104","author":"Orlando","year":"2009","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.jceh.2014.04.003_bib151","first-page":"66","article-title":"Radiofrequency ablation of liver tumors: experience with open and percutaneous approach","volume":"25","author":"Chhabra","year":"2006","journal-title":"Indian J Gastroenterol"},{"issue":"4","key":"10.1016\/j.jceh.2014.04.003_bib152","first-page":"183","article-title":"Radiofrequency ablation: a new therapeutic modality for the management of hepatocellular cancer","volume":"23","author":"Gulati","year":"2002","journal-title":"Trop Gastroenterol"},{"issue":"6","key":"10.1016\/j.jceh.2014.04.003_bib153","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1002\/cncr.20892","article-title":"Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases","volume":"103","author":"Tateishi","year":"2005","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.jceh.2014.04.003_bib154","doi-asserted-by":"crossref","first-page":"121","DOI":"10.4103\/0971-3026.82296","article-title":"Technical note: radiofrequency ablation of hepatocellular carcinoma with contrast-enhanced ultrasound guidance: first Indian experience","volume":"21","author":"Kapoor","year":"2011","journal-title":"Indian J Radiol Imaging"},{"issue":"5","key":"10.1016\/j.jceh.2014.04.003_bib155","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.ejca.2011.12.021","article-title":"EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma","volume":"48","year":"2012","journal-title":"Eur J Cancer"},{"issue":"3","key":"10.1016\/j.jceh.2014.04.003_bib156","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/01.sla.0000201480.65519.b8","article-title":"A\u00a0prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma","volume":"243","author":"Chen","year":"2006","journal-title":"Ann Surg"},{"issue":"6","key":"10.1016\/j.jceh.2014.04.003_bib157","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1097\/SLA.0b013e3181efc656","article-title":"A\u00a0randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the Milan criteria","volume":"252","author":"Huang","year":"2010","journal-title":"Ann Surg"},{"issue":"3","key":"10.1016\/j.jceh.2014.04.003_bib158","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3109\/15368378.2012.721849","article-title":"Modeling and simulation of novel antenna for\u00a0the treatment of hepatocellular carcinoma using finite element method","volume":"32","author":"Maini","year":"2013","journal-title":"Electromagn Biol Med"},{"issue":"3","key":"10.1016\/j.jceh.2014.04.003_bib159","first-page":"125","article-title":"Palliative treatment in advanced hepatocellular carcinoma: has it made any difference?","volume":"30","author":"Paul","year":"2009","journal-title":"Trop Gastroenterol"},{"issue":"3","key":"10.1016\/j.jceh.2014.04.003_bib160","first-page":"96","article-title":"Therapeutic radiological interventional procedures in hepatocellular carcinoma","volume":"21","author":"Srivastava","year":"2002","journal-title":"Indian J Gastroenterol"},{"issue":"9319","key":"10.1016\/j.jceh.2014.04.003_bib161","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1016\/S0140-6736(02)08649-X","article-title":"Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial","volume":"359","author":"Llovet","year":"2002","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.jceh.2014.04.003_bib162","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1053\/jhep.2002.33156","article-title":"Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma","volume":"35","author":"Lo","year":"2002","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.jceh.2014.04.003_bib163","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1053\/j.gastro.2006.05.021","article-title":"Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients","volume":"131","author":"Takayasu","year":"2006","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.jceh.2014.04.003_bib164","first-page":"176","article-title":"Transcatheter arterial chemoembolization in hepatocellular carcinoma: technique, effects and present status","volume":"24","author":"Paul","year":"2003","journal-title":"Trop Gastroenterol"},{"issue":"9","key":"10.1016\/j.jceh.2014.04.003_bib165","doi-asserted-by":"crossref","first-page":"405","DOI":"10.4329\/wjr.v4.i9.405","article-title":"Embolization of liver tumors: past, present and future","volume":"4","author":"Rammohan","year":"2012","journal-title":"World J Radiol"},{"issue":"3","key":"10.1016\/j.jceh.2014.04.003_bib166","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1148\/radiol.11081489","article-title":"Transcatheter intraarterial therapies: rationale and overview","volume":"259","author":"Lewandowski","year":"2011","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.jceh.2014.04.003_bib167","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1148\/radiology.198.1.8539401","article-title":"Hepatic tumors: predisposing factors for complications of transcatheter oily chemoembolization","volume":"198","author":"Chung","year":"1996","journal-title":"Radiology"},{"issue":"6","key":"10.1016\/j.jceh.2014.04.003_bib168","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1002\/cncr.10407","article-title":"A\u00a0prospective study regarding the complications of transcatheter intraarterial lipiodol chemoembolization in patients with hepatocellular carcinoma","volume":"94","author":"Chan","year":"2002","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.jceh.2014.04.003_bib169","doi-asserted-by":"crossref","first-page":"339","DOI":"10.4103\/0019-509X.84941","article-title":"Transarterial chemoembolization for hepatocellular carcinoma: significance of extrahepatic collateral supply","volume":"48","author":"Paul","year":"2011","journal-title":"Indian J Cancer"},{"issue":"19","key":"10.1016\/j.jceh.2014.04.003_bib170","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1056\/NEJM199505113321903","article-title":"A\u00a0comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. Groupe d\u2019Etude et de Traitement du Carcinome H\u00e9patocellulaire","volume":"332","year":"1995","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.jceh.2014.04.003_bib171","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1053\/jhep.2003.50047","article-title":"Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival","volume":"37","author":"Llovet","year":"2003","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.jceh.2014.04.003_bib172","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1148\/radiol.2241011262","article-title":"Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials","volume":"224","author":"Camm\u00e0","year":"2002","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.jceh.2014.04.003_bib173","doi-asserted-by":"crossref","first-page":"113","DOI":"10.4103\/0971-3026.82294","article-title":"Trans-arterial chemoembolization (TACE) in patients with unresectable hepatocellular carcinoma: experience from a tertiary care centre in India","volume":"21","author":"Paul","year":"2011","journal-title":"Indian J Radiol Imaging"},{"key":"10.1016\/j.jceh.2014.04.003_bib174","first-page":"CD004787","article-title":"Transarterial (chemo)embolisation for unresectable hepatocellular carcinoma","volume":"3","author":"Oliveri","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.jceh.2014.04.003_bib175","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.jhep.2006.10.020","article-title":"Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics","volume":"46","author":"Varela","year":"2007","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.jceh.2014.04.003_bib176","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00270-009-9711-7","article-title":"Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study","volume":"33","author":"Lammer","year":"2010","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"2","key":"10.1016\/j.jceh.2014.04.003_bib177","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jvir.2012.10.025","article-title":"Single-center comparison of three chemoembolization regimens for hepatocellular carcinoma","volume":"24","author":"Petruzzi","year":"2013","journal-title":"J\u00a0Vasc Interv Radiol"},{"issue":"3","key":"10.1016\/j.jceh.2014.04.003_bib178","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jvir.2012.11.023","article-title":"Safety and efficacy of drug-eluting bead chemoembolization for hepatocellular carcinoma: comparison of small-versus medium-size particles","volume":"24","author":"Padia","year":"2013","journal-title":"J\u00a0Vasc Interv Radiol"},{"issue":"3","key":"10.1016\/j.jceh.2014.04.003_bib179","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.jvir.2012.11.026","article-title":"Safety and efficacy of doxorubicin drug-eluting bead transarterial chemoembolization in patients with advanced hepatocellular carcinoma","volume":"24","author":"Prajapati","year":"2013","journal-title":"J\u00a0Vasc Interv Radiol"},{"issue":"1","key":"10.1016\/j.jceh.2014.04.003_bib180","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.diii.2012.05.001","article-title":"Result and cost of hepatic chemoembolisation with drug eluting beads in 21 patients","volume":"94","author":"Vadot","year":"2013","journal-title":"Diagn Interv Imaging"},{"issue":"1","key":"10.1016\/j.jceh.2014.04.003_bib181","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s00270-006-0062-3","article-title":"Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies","volume":"30","author":"Marelli","year":"2007","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"3","key":"10.1016\/j.jceh.2014.04.003_bib182","first-page":"185","article-title":"Improved time to progression for transarterial chemoembolization compared with transarterial embolization for patients with unresectable hepatocellular carcinoma","volume":"11","author":"Morse","year":"2012","journal-title":"Clin Colorectal Cancer"},{"issue":"2","key":"10.1016\/j.jceh.2014.04.003_bib183","first-page":"62","article-title":"Radionuclide therapy for hepatocellular carcinoma: indication, cost and efficacy","volume":"29","author":"Bal","year":"2008","journal-title":"Trop Gastroenterol"},{"issue":"2","key":"10.1016\/j.jceh.2014.04.003_bib184","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1148\/radiol.2432051246","article-title":"Inoperable hepatocellular carcinoma: transarterial 188Re HDD-labeled iodized oil for treatment\u2013prospective multicenter clinical trial","volume":"243","author":"Kumar","year":"2007","journal-title":"Radiology"},{"issue":"8","key":"10.1016\/j.jceh.2014.04.003_bib185","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1111\/j.1600-6143.2009.02695.x","article-title":"A\u00a0comparative analysis of transarterial downstaging for hepatocellular carcinoma: chemoembolization versus radioembolization","volume":"9","author":"Lewandowski","year":"2009","journal-title":"Am J Transplant"},{"issue":"1","key":"10.1016\/j.jceh.2014.04.003_bib186","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1053\/j.gastro.2009.09.006","article-title":"Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes","volume":"138","author":"Salem","year":"2010","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.jceh.2014.04.003_bib187","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.jceh.2014.04.003_bib188","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1470-2045(08)70285-7","article-title":"Efficacy and safety of sorafenib in patients in the Asia\u2013Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial","volume":"10","author":"Cheng","year":"2009","journal-title":"Lancet Oncol"},{"issue":"7","key":"10.1016\/j.jceh.2014.04.003_bib189","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1742-1241.2012.02940.x","article-title":"First interim analysis of the GIDEON (Global Investigation of therapeutic decisions in hepatocellular carcinoma and of its treatment with sorafenib) non-interventional study","volume":"66","author":"Lencioni","year":"2012","journal-title":"Int J Clin Pract"},{"issue":"suppl 7","key":"10.1016\/j.jceh.2014.04.003_bib190","doi-asserted-by":"crossref","first-page":"vii41","DOI":"10.1093\/annonc\/mds225","article-title":"Hepatocellular carcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"23","author":"Verslype","year":"2012","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.jceh.2014.04.003_bib191","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.24199","article-title":"Management of hepatocellular carcinoma: an update","volume":"53","author":"Bruix","year":"2011","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.jceh.2014.04.003_bib192","first-page":"115","article-title":"A\u00a0phase II study of gemcitabine and cisplatin in patients with advanced hepatocellular carcinoma","volume":"26","author":"Parikh","year":"2005","journal-title":"Trop Gastroenterol"},{"issue":"1","key":"10.1016\/j.jceh.2014.04.003_bib193","doi-asserted-by":"crossref","first-page":"42","DOI":"10.4103\/0971-5851.96968","article-title":"Gemcitabine and cisplatin-based combination chemotherapy in advanced hepatocellular carcinoma: an Indian experience","volume":"33","author":"Pande","year":"2012","journal-title":"Indian J Med Paediatr Oncol"},{"issue":"9","key":"10.1016\/j.jceh.2014.04.003_bib194","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1111\/j.1440-1746.2006.04383.x","article-title":"High dose vitamin K3 infusion in advanced hepatocellular carcinoma","volume":"21","author":"Sarin","year":"2006","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.jceh.2014.04.003_bib195","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1477-2574.2010.00183.x","article-title":"Nonoperative therapies for combined modality treatment of hepatocellular cancer: expert consensus statement","volume":"12","author":"Schwarz","year":"2010","journal-title":"HPB (Oxford)"},{"issue":"4","key":"10.1016\/j.jceh.2014.04.003_bib196","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1245\/s10434-007-9729-5","article-title":"Radiotherapy for hepatocellular carcinoma: an overview","volume":"15","author":"Krishnan","year":"2008","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"10.1016\/j.jceh.2014.04.003_bib197","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1002\/cncr.21811","article-title":"Radiation therapy for hepatocellular carcinoma: from palliation to cure","volume":"106","author":"Hawkins","year":"2006","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.jceh.2014.04.003_bib198","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/00000421-199208000-00005","article-title":"Combination chemotherapy and radiation for palliation of hepatocellular carcinoma","volume":"15","author":"Dhir","year":"1992","journal-title":"Am J Clin Oncol"},{"issue":"3","key":"10.1016\/j.jceh.2014.04.003_bib199","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","article-title":"New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada","volume":"92","author":"Therasse","year":"2000","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"1","key":"10.1016\/j.jceh.2014.04.003_bib200","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1055\/s-0030-1247132","article-title":"Modified RECIST (mRECIST) assessment for hepatocellular carcinoma","volume":"30","author":"Lencioni","year":"2010","journal-title":"Semin Liver Dis"},{"issue":"2","key":"10.1016\/j.jceh.2014.04.003_bib201","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1001\/archsurg.2007.39","article-title":"Recurrence of hepatocellular carcinoma following liver transplantation: a review of preoperative and postoperative prognostic indicators","volume":"143","author":"Zimmerman","year":"2008","journal-title":"Arch Surg"},{"issue":"5","key":"10.1016\/j.jceh.2014.04.003_bib202","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.gcb.2009.02.036","article-title":"Natural history and therapeutic management of recurrent hepatocellular carcinoma after liver transplantation","volume":"33","author":"Hollebecque","year":"2009","journal-title":"Gastroenterol Clin Biol"},{"issue":"suppl 2","key":"10.1016\/j.jceh.2014.04.003_bib203","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1002\/lt.20605","article-title":"Tumor surveillance-what can and should be done? Screening for recurrence of hepatocellular carcinoma after liver transplantation","volume":"11","author":"Roberts","year":"2005","journal-title":"Liver Transpl"},{"issue":"6","key":"10.1016\/j.jceh.2014.04.003_bib204","doi-asserted-by":"crossref","first-page":"889","DOI":"10.2217\/fon.09.64","article-title":"Role of alpha-fetoprotein in hepatocellular carcinoma: prognostication, treatment monitoring or both?","volume":"5","author":"Chan","year":"2009","journal-title":"Future Oncol"},{"issue":"5","key":"10.1016\/j.jceh.2014.04.003_bib205","first-page":"363","article-title":"Diagnostic and prognostic value of alpha-fetoprotein, des-\u03b3-carboxy prothrombin and squamous cell carcinoma antigen immunoglobulin M complexes in hepatocellular carcinoma","volume":"102","author":"Bertino","year":"2011","journal-title":"Minerva Med"},{"issue":"6","key":"10.1016\/j.jceh.2014.04.003_bib206","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1373\/clinchem.2009.133124","article-title":"National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for use of tumor markers in liver, bladder, cervical, and gastric cancers","volume":"56","author":"Sturgeon","year":"2010","journal-title":"Clin Chem"},{"issue":"7","key":"10.1016\/j.jceh.2014.04.003_bib207","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3949\/ccjm.78a.10054","article-title":"Managing cancer pain: frequently asked questions","volume":"78","author":"Induru","year":"2011","journal-title":"Cleve Clin J Med"},{"issue":"3 suppl l","key":"10.1016\/j.jceh.2014.04.003_bib208","doi-asserted-by":"crossref","first-page":"ES39","DOI":"10.36076\/ppj.2012\/15\/ES39","article-title":"A\u00a0systematic review of randomized trials on the effectiveness of opioids for cancer pain","volume":"15","author":"Koyyalagunta","year":"2012","journal-title":"Pain Physician"},{"issue":"5","key":"10.1016\/j.jceh.2014.04.003_bib209","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1177\/030089161109700512","article-title":"Defining the role of palliative radiotherapy in bone metastasis from primary liver cancer: an analysis of survival and treatment efficacy","volume":"97","author":"Habermehl","year":"2011","journal-title":"Tumori"},{"issue":"3","key":"10.1016\/j.jceh.2014.04.003_bib210","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.ijrobp.2008.11.065","article-title":"Helical tomotherapy for simultaneous multitarget radiotherapy for pulmonary metastasis","volume":"75","author":"Kim","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.jceh.2014.04.003_bib211","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.ijrobp.2009.08.047","article-title":"Absence of symptom and intact liver function are positive prognosticators for patients undergoing radiotherapy for lymph node metastasis from hepatocellular carcinoma","volume":"78","author":"Kim","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.jceh.2014.04.003_bib212","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1080\/01635581.2012.675620","article-title":"Mini-nutritional assessment predicts functional status and quality of life of patients with hepatocellular carcinoma in Taiwan","volume":"64","author":"Hsu","year":"2012","journal-title":"Nutr Cancer"},{"key":"10.1016\/j.jceh.2014.04.003_bib213","first-page":"CD008344","article-title":"Nutritional support for liver disease","volume":"5","author":"Koretz","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"22","key":"10.1016\/j.jceh.2014.04.003_bib214","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1001\/jama.284.22.2907","article-title":"Depression, hopelessness, and desire for hastened death in terminally ill patients with cancer","volume":"284","author":"Breitbart","year":"2000","journal-title":"JAMA"},{"issue":"18","key":"10.1016\/j.jceh.2014.04.003_bib215","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1001\/archinte.1994.00420180041005","article-title":"Patient requests to hasten death. Evaluation and management in terminal care","volume":"154","author":"Block","year":"1994","journal-title":"Arch Intern Med"},{"issue":"4","key":"10.1016\/j.jceh.2014.04.003_bib216","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/s002610000056","article-title":"Gastrointestinal hemorrhage in hepatocellular carcinoma: management with transheptic arterioembolization","volume":"25","author":"Srivastava","year":"2000","journal-title":"Abdom Imaging"},{"issue":"48","key":"10.1016\/j.jceh.2014.04.003_bib217","doi-asserted-by":"crossref","first-page":"7302","DOI":"10.3748\/wjg.v18.i48.7302","article-title":"Predictors and clinical outcomes for spontaneous rupture of hepatocellular carcinoma","volume":"18","author":"Zhu","year":"2012","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10.1016\/j.jceh.2014.04.003_bib218","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1001\/archsurg.141.2.191","article-title":"Spontaneous rupture of hepatocellular carcinoma: a systematic review","volume":"141","author":"Lai","year":"2006","journal-title":"Arch Surg"},{"issue":"1\u20132","key":"10.1016\/j.jceh.2014.04.003_bib219","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s11010-013-1582-1","article-title":"Dietary supplementation of silymarin is associated with decreased cell proliferation, increased apoptosis, and activation of detoxification system in hepatocellular carcinoma","volume":"377","author":"Gopalakrishnan","year":"2013","journal-title":"Mol Cell Biochem"},{"issue":"3","key":"10.1016\/j.jceh.2014.04.003_bib220","doi-asserted-by":"crossref","first-page":"448","DOI":"10.4103\/0377-4929.85073","article-title":"Expansion of peripheral and intratumoral regulatory T-cells in hepatocellular carcinoma: a case-control study","volume":"54","author":"Thakur","year":"2011","journal-title":"Indian J Pathol Microbiol"},{"issue":"3","key":"10.1016\/j.jceh.2014.04.003_bib221","doi-asserted-by":"crossref","first-page":"323","DOI":"10.4103\/0377-4929.42504","article-title":"Angiogenesis in liver cirrhosis and hepatocellular carcinoma","volume":"51","author":"Amarapurkar","year":"2008","journal-title":"Indian J Pathol Microbiol"},{"issue":"3","key":"10.1016\/j.jceh.2014.04.003_bib222","first-page":"395","article-title":"Reactive oxygen species damaged human serum albumin in patients with hepatocellular carcinoma","volume":"26","author":"Rasheed","year":"2007","journal-title":"J\u00a0Exp Clin Cancer Res"},{"issue":"8","key":"10.1016\/j.jceh.2014.04.003_bib223","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.2217\/nnm.12.166","article-title":"Anticancer efficacy of a novel propofol-linoleic acid-loaded escheriosomal formulation against murine hepatocellular carcinoma","volume":"8","author":"Khan","year":"2013","journal-title":"Nanomedicine (Lond)"}],"container-title":["Journal of Clinical and Experimental Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688314002710?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688314002710?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T06:03:07Z","timestamp":1760853787000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0973688314002710"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":223,"alternative-id":["S0973688314002710"],"URL":"https:\/\/doi.org\/10.1016\/j.jceh.2014.04.003","relation":{},"ISSN":["0973-6883"],"issn-type":[{"value":"0973-6883","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Indian National Association for Study of the Liver (INASL) Consensus on Prevention, Diagnosis and Management of Hepatocellular Carcinoma in India: The\u00a0Puri Recommendations","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical and Experimental Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jceh.2014.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 INASL. Published by Elsevier, a division of Reed Elsevier India, Pvt. Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}